Why Is Health Care Company Fortrea Stock Diving Today?
Why Is Health Care Company Fortrea Stock Diving Today?
Fortrea Holdings Inc. (NASDAQ:FTRE) shares are trading lower after the company reported soft first-quarter FY24 results and cut its revenue outlook.
Fortrea Holdings Inc.（納斯達克股票代碼：FTRE）公佈了疲軟的24財年第一季度業績並下調了收入前景後，該公司股價走低。
Revenue of $662.1 million missed the consensus of $754.6 million. As of March-end, the backlog stood at $7.4 billion, and the book-to-bill ratio for the quarter was 1.11x.
6.621億美元的收入未達到7.546億美元的共識。截至3月底，積壓量爲74億美元，該季度的賬面賬單比率爲1.11倍。
Adjusted EBITDA stood at $29.5 million, a decline from $41.7 million a year ago. Adjusted EPS of $(0.04) missed the street view of $0.01.
調整後的息稅折舊攤銷前利潤爲2950萬美元，低於去年同期的4,170萬美元。調整後的每股收益爲0.04美元，未達到0.01美元的街景。
In the quarter, operating cash flow came in at $(25.6) million, and free cash flow was $(34.9) million. As of March-end, cash and cash equivalents stood at $92.8 million, and gross debt was $1.65 billion.
在本季度，運營現金流爲2560萬美元，自由現金流爲3,490萬美元。截至3月底，現金及現金等價物爲9,280萬美元，債務總額爲16.5億美元。
Tom Pike, chairman and CEO of Fortrea, said, "The demand for our services is good. Our business operations are sound even as we continue to knock down challenges related to the unique circumstances of our 2023 spin-out and before."
Fortrea董事長兼首席執行官湯姆·派克表示：“對我們服務的需求良好。儘管我們繼續應對與2023年及之前分拆的獨特情況相關的挑戰，但我們的業務運營仍然健全。”
"We have made strong progress with the planned exits of our Transition Services Agreements with our former parent company, and our planned divestment of our Endpoint and Patient Access businesses is making good progress."
“我們在計劃退出與前母公司的過渡服務協議方面取得了長足的進展，我們對終端和患者准入業務的計劃也取得了良好的進展。”
FY24 Outlook: The company cut the revenue guidance to $2.785 billion-$2.855 billion from $3.14 billion-$3.205 billion (vs. estimate of $3.08 billion).
24財年展望：該公司將收入預期從31.4億美元至32.05億美元下調至27.85億美元至28.55億美元（而估計爲30.8億美元）。
Also, Fortrea trimmed adjusted EBITDA guidance to $240.0 million-$260.0 million from $280 million-$320 million.
此外，Fortrea將調整後的息稅折舊攤銷前利潤預期從2.8億美元至3.2億美元下調至2.4億美元至2.6億美元。
In March, the company inked a deal to divest assets related to its Enabling Services segment, namely its Endpoint Clinical and Fortrea Patient Access businesses, to an affiliate of Arsenal Capital Partners.
3月，該公司簽署了一項協議，將與其賦能服務板塊（即其Endpoint Clinical和Fortrea Patient Access業務）相關的資產剝離給阿森納資本合夥人的子公司。
The transaction is expected to close in the second quarter, subject to customary closing conditions and regulatory approvals.
該交易預計將在第二季度完成，但須遵守慣例成交條件和監管部門的批准。
Investors can gain exposure to the stock via Invesco S&P SmallCap Health Care ETF (NASDAQ:PSCH) and Vanguard S&P Small-Cap 600 Value ETF (NYSE:VIOV).
投資者可以通過景順標普小盤股醫療保健ETF（納斯達克股票代碼：PSCH）和Vanguard標普小盤股600價值ETF（紐約證券交易所代碼：VIOV）獲得股票敞口。
Price Action: FTRE shares are down 14% at $28.41 at the last check Monday.
價格走勢：在週一的最後一次檢查中，FTRE股價下跌了14％，至28.41美元。
Photo via Shutterstock
照片來自 Shutterstock
譯文內容由第三人軟體翻譯。